Nitrous oxide cryotherapy for primary periocular basal cell carcinoma: outcome at 5 years follow-up

Br J Ophthalmol. 2011 Dec;95(12):1679-81. doi: 10.1136/bjo.2009.173021. Epub 2010 Sep 9.

Abstract

Aim: To report the outcome at 5-year follow-up of a defined series of patients with primary periocular basal cell carcinoma treated by cryotherapy using a nitrous oxide probe.

Methods: A prospective, non-comparative, interventional case series. One hundred primary periocular basal cell carcinomas were treated with a double freeze-thaw cycle nitrous oxide contact cryotherapy probe. Inclusion criteria were clinically well-defined primary periocular basal cell carcinomas with maximum diameter of 8 mm. The main outcome measure was histologically proven recurrence rate at 5-year follow-up.

Results: Kaplan-Meier survival analysis showed a 5-year recurrence rate of 8%. Cox regression analysis revealed no correlation between tumour site, tumour size, cryotherapy freeze time and recurrence (p=0.60, p=0.86 and p=0.71, respectively). Thirty-six per cent of patients were lost to follow-up at 5 years following treatment.

Conclusion: The results of this series suggest that nitrous oxide probe cryotherapy for primary periocular basal cell carcinomas up to 8 mm diameter has a recurrence rate of ∼8%. Cryotherapy has certain advantages over surgical removal of tumours of this size in the periocular region, but careful follow-up is advisable.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Basal Cell / mortality
  • Carcinoma, Basal Cell / pathology
  • Carcinoma, Basal Cell / therapy*
  • Cryotherapy / instrumentation
  • Cryotherapy / methods*
  • Eyelid Neoplasms / mortality
  • Eyelid Neoplasms / pathology
  • Eyelid Neoplasms / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnosis*
  • Nitrous Oxide / therapeutic use*
  • Proportional Hazards Models
  • Prospective Studies
  • Treatment Outcome

Substances

  • Nitrous Oxide